These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 11490549)

  • 21. Behavioral disturbances in Alzheimer's disease: a non-pharmacological therapeutic approach.
    Silvestri A; Rosano G; Zannino G; Ricca F; Marigliano V; Fini M
    Arch Gerontol Geriatr Suppl; 2004; (9):379-86. PubMed ID: 15207436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive and behavioral features discriminate between Alzheimer's and Parkinson's disease.
    Cahn-Weiner DA; Grace J; Ott BR; Fernandez HH; Friedman JH
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Jun; 15(2):79-87. PubMed ID: 12050470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease.
    Lanari A; Amenta F; Silvestrelli G; Tomassoni D; Parnetti L
    Mech Ageing Dev; 2006 Feb; 127(2):158-65. PubMed ID: 16297434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
    Amieva H; Le Goff M; Millet X; Orgogozo JM; Pérès K; Barberger-Gateau P; Jacqmin-Gadda H; Dartigues JF
    Ann Neurol; 2008 Nov; 64(5):492-8. PubMed ID: 19067364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's disease management.
    Rabins PV
    J Clin Psychiatry; 1998; 59 Suppl 13():36-8. PubMed ID: 9771829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Geriatric psychopharmacology. Management of late-life depression and the noncognitive behavioral disturbances of Alzheimer's disease.
    Raskind MA
    Psychiatr Clin North Am; 1993 Dec; 16(4):815-27. PubMed ID: 7906030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of serotonin in the behavioral and psychological symptoms of dementia.
    Lanctôt KL; Herrmann N; Mazzotta P
    J Neuropsychiatry Clin Neurosci; 2001; 13(1):5-21. PubMed ID: 11207325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years.
    Mondadori CR; Buchmann A; Mustovic H; Schmidt CF; Boesiger P; Nitsch RM; Hock C; Streffer J; Henke K
    Brain; 2006 Nov; 129(Pt 11):2908-22. PubMed ID: 17012294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia.
    Engelborghs S; Vloeberghs E; Le Bastard N; Van Buggenhout M; Mariën P; Somers N; Nagels G; Pickut BA; De Deyn PP
    Neurochem Int; 2008 May; 52(6):1052-60. PubMed ID: 18093695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clusters of cognitive and behavioral disorders clearly distinguish primary progressive aphasia from frontal lobe dementia, and Alzheimer's disease.
    Marra C; Quaranta D; Zinno M; Misciagna S; Bizzarro A; Masullo C; Daniele A; Gainotti G
    Dement Geriatr Cogn Disord; 2007; 24(5):317-26. PubMed ID: 17851236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Early diagnosis of Alzheimer disease].
    Touchon J; Ritchie K; Gely-Nargeot MC
    Ann Med Interne (Paris); 1998 Jun; 149(4):193-201. PubMed ID: 11490546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in the behavioral and psychological symptoms between Alzheimer's disease and vascular dementia: are the different pharmacologic treatment strategies justifiable?
    Kim JM; Lyons D; Shin IS; Yoon JS
    Hum Psychopharmacol; 2003 Apr; 18(3):215-20. PubMed ID: 12672174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the slopes of cognitive impairment and disability in Alzheimer's disease (AD) patients treated with acetylcholinesterase inhibitors (AChEl).
    Campanozzi MD; Casali E; Neviani F; Martini E; Neri M
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():91-6. PubMed ID: 17317439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.
    Bonanni L; Thomas A; Tiraboschi P; Perfetti B; Varanese S; Onofrj M
    Brain; 2008 Mar; 131(Pt 3):690-705. PubMed ID: 18202105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I.
    Aalten P; Verhey FR; Boziki M; Bullock R; Byrne EJ; Camus V; Caputo M; Collins D; De Deyn PP; Elina K; Frisoni G; Girtler N; Holmes C; Hurt C; Marriott A; Mecocci P; Nobili F; Ousset PJ; Reynish E; Salmon E; Tsolaki M; Vellas B; Robert PH
    Dement Geriatr Cogn Disord; 2007; 24(6):457-63. PubMed ID: 17986816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
    Beier MT
    Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apathy and depression in Alzheimer's disease are associated with functional deficit and psychotropic prescription.
    Benoit M; Andrieu S; Lechowski L; Gillette-Guyonnet S; Robert PH; Vellas B;
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):409-14. PubMed ID: 17918770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of behavioral versus cognitive measures in differentiating between subtypes of frontotemporal lobar degeneration and Alzheimer's disease.
    Heidler-Gary J; Gottesman R; Newhart M; Chang S; Ken L; Hillis AE
    Dement Geriatr Cogn Disord; 2007; 23(3):184-93. PubMed ID: 17220629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influence of treatment with acetyl-cholinesterase inhibitors on psychopathological symptoms in Alzheimer's disease].
    Rösler M; Frey U
    Fortschr Neurol Psychiatr; 2002 Feb; 70(2):78-83. PubMed ID: 11823923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.